Targeting ITGA5 to inhibit breast cancer cell migration has been recently achieved through different approaches with decreased metastasis capacity, thus demonstrating the potential of this approach for breast cancer therapy [21, 36, 37]. This evidence concerns the gene ITGA5 and breast carcinoma.